Evaluation of Factors Influencing Antibody Reduction for Development of Antibody Drug Conjugates

BACKGROUND: Reduction/alkylation is one of the leading strategies for the development of antibody drug conjugates (ADCs). Precise control of the reduction process would not only yield a defined number of free thiols per antibody but also result in development of more homogenous conjugates. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdollahpour-Alitappeh, Meghdad, Lotfinia, Majid, Razavi-Vakhshourpour, Sepand, Jahandideh, Saeed, Najminejad, Hamid, Sepehr, Koushan Sineh, Moazami, Reza, Shams, Elnaz, Habibi-Anbouhi, Mahdi, Abolhassani, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pasteur Institute 2017
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459942/
https://www.ncbi.nlm.nih.gov/pubmed/28410549
http://dx.doi.org/10.18869/acadpub.ibj.21.4.270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459942/
https://www.ncbi.nlm.nih.gov/pubmed/28410549
http://dx.doi.org/10.18869/acadpub.ibj.21.4.270

Ejemplares similares